Wong, Risa L.
Duong, Mai T.
Tangen, Catherine M.
Agarwal, Neeraj
Cheng, Heather H.
Vogelzang, Nicholas J.
Hussain, Maha
Thompson, Ian M. Jr.
Quinn, David I.
Yu, Evan Y.
Funding for this research was provided by:
Please see funding details listed under the Corresponding Author
Article History
Received: 18 December 2019
Revised: 16 January 2020
Accepted: 28 January 2020
First Online: 13 February 2020
Compliance with ethical standards
:
: EY has received research support from Dendreon, Merck, and Seattle Genetics and consulted for Bayer, Clovis, Dendreon, Janssen, and Merck. NA has consulted for Astellas, AstraZeneca, BMS, Bayer, Clovis, Eisai, Exelixis, EMD Serono, Eli Lilly, Foundation Medicine, Genentech, Janssen, Merck, Novartis, Nektar, Pfizer, and Pharmacyclics. HC has received research support from Clovis, Janssen, Medivation, and Sanofi. MH has received honoraria from Aptitude Health, Astellas, Epics, Genentech, PER, Research to Practice, and Sanofi/Genzyme, consulted for AstraZeneca, Bayer, and Pfizer, received research support from AstraZeneca, Bayer, Genentech, and Pfizer, and received travel and accommodation support from Astellas, AstraZeneca, Bayer, Genentech, and Pfizer. DQ has consulted for Astellas, Bayer, Janssen, Pfizer, Sanofi, and AstraZeneca. The other authors declare that they have no conflict of interest.